BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30689118)

  • 1. Increased
    Okuyama C; Matsushima S; Nishimura M; Yamada K
    Ann Nucl Med; 2019 May; 33(5):368-373. PubMed ID: 30689118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of physiologic and abnormal glucose uptake in palatine tonsils: differential diagnostics with sequential dual-time-point 2-deoxy-2-[18F]FDG PET/CT.
    Pietrzak AK; Kazmierska J; Marszalek A; Cholewinski W
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):299-306. PubMed ID: 30221906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study.
    Wong WL; Gibson D; Sanghera B; Goodchild K; Saunders M
    Nucl Med Commun; 2007 Sep; 28(9):675-80. PubMed ID: 17667745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of physiological uptake of 18F-fluorodeoxyglucose in palatine tonsils.
    Birkin E; Moore KS; Huang C; Christopher M; Rees JI; Jayaprakasam V; Fielding PA
    Medicine (Baltimore); 2018 Jun; 97(24):e11040. PubMed ID: 29901601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal FDG uptake in the adenoids and palatine tonsils in children on PET/MRI.
    Kumbhar SS; Qi J
    Pediatr Radiol; 2020 Jun; 50(7):958-965. PubMed ID: 32198664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma.
    Yamaguchi S; Hirata K; Kobayashi H; Shiga T; Manabe O; Kobayashi K; Motegi H; Terasaka S; Houkin K
    Ann Nucl Med; 2014 Aug; 28(7):603-9. PubMed ID: 24743915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.
    Davison JM; Ozonoff A; Imsande HM; Grillone GA; Subramaniam RM
    Radiology; 2010 May; 255(2):578-85. PubMed ID: 20413767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Increased FDG Uptake in the Waldeyer Ring and the Nasopharynx Region Identified by PET-CT in Postchemotherapy Follow-up in Patients With Lymphoma: When Should We Perform Biopsy?
    Kurtoğlu E; Göçer M
    Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):830-835. PubMed ID: 32917575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT findings within the contralateral tonsil following unilateral tonsillectomy.
    Hirshoren N; Olayos E; Callahan J; Lau E
    Laryngoscope; 2016 Nov; 126(11):2480-2483. PubMed ID: 27114188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT in primary brain lymphoma.
    Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F
    J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma metastases to palatine tonsils obscured by physiological FDG uptake on PET/CT.
    Al-Ibraheem A; Souvatzoglou M; Buck A; Schwaiger M
    Clin Nucl Med; 2010 Feb; 35(2):101-2. PubMed ID: 20090457
    [No Abstract]   [Full Text] [Related]  

  • 14. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.
    Jorgov L; Montravers F; Balogova S; Ragu C; Pacquement H; Leblanc T; Abbou S; Ducou-Lepointe H; Landman-Parker J; Talbot JN
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1220-30. PubMed ID: 26660144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound adenotonsillar and thymic uptake of 18F-FDG in paediatric patients with lymphoma.
    Hu YY; Zhao YM; Zhang X; Zhou C; Li YH; Long W; Fan W
    Eur J Radiol; 2020 Dec; 133():109348. PubMed ID: 33099222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual FDG uptake of primary thyroid lymphoma after treatment may overestimate residual lymphoma.
    Fujii H; Nakadate M; Tanaka H; Harata N; Oota S; Isogai J; Yoshida K
    Ann Nucl Med; 2016 Dec; 30(10):756-759. PubMed ID: 27614754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma.
    Goethals I; Hoste P; De Vriendt C; Smeets P; Verlooy J; Ham H
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):462-7. PubMed ID: 19820931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
    Ponisio MR; McConathy J; Laforest R; Khanna G
    Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG uptake in the normal appendix in adults: PET/CT evaluation.
    Silman C; Matsumoto S; Ono A; Kiyonaga M; Otsuka K
    Ann Nucl Med; 2019 Apr; 33(4):265-268. PubMed ID: 30652242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental FDG-Avid Focuses in Palatine Tonsils on PET/CT.
    Reinholdt KB; Dias AH; Hoff CM; Gormsen LC; Klug TE
    Laryngoscope; 2022 Dec; 132(12):2370-2378. PubMed ID: 35226376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.